Home / Life Sciences

Legal News

Non-confidential version of the Pfizer-Flynn Pharma infringement decision released

Copyright © 2025 LexisNexis
Published on: 22 February 2023
Published by LNB News

LNB News 22/02/2023

Document Information

Issue Date: 22 February 2023

Published Date: 22 February 2023

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Competition and Markets Authority (CMA) has published the non-confidential version of the infringement decision in Pfizer and Flynn Pharma (phenytoin sodium capsules) (Case 50908) from 21 July 2022 involving unfair pricing of an epilepsy drug.

Powered by Lexis+®
Jurisdiction(s):
England, Northern Ireland, Scotland and Wales

Popular documents

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Contributory negligence in personal injury claims

Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of